Evidence map›Paper›PMID 27942212›Full record

ArticleInternational journal of nanomedicine

Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.

Rudra Pangeni, Sang Won Choi, Ok-Cheol Jeon, Youngro Byun, Jin Woo Park

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in International journal of nanomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Recent Insights into Nanotechnology in Colorectal Cancer.Applied biochemistry and biotechnology · 2024
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Current approaches in lipid-based nanocarriers for oral drug delivery.Drug delivery and translational research · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Rudra PangeniDepartment of Pharmacy, College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun.
Sang Won ChoiDepartment of Pharmacy, College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun.
Ok-Cheol JeonPharosgen R&D Center, Asan Institute for Life Sciences.
Youngro ByunDepartment of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Jin Woo ParkDepartment of Pharmacy, College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun.
Mokpo National University · KRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxaliplatin (OXA) is a third-generation cisplatin analog that has been approved as first-line chemotherapy in combination with 5-fluorouracil (5-FU) for the treatment of resectable and advanced colorectal cancer. However, the therapeutic efficacy of oral OXA and 5-FU is limited by their low bioavailability due to poor membrane permeability. The aim of the present study was to develop an oral delivery system for OXA and 5-FU. We constructed an ion-pairing complex of OXA with a deoxycholic acid derivative (N

Indexed as

EmulsionsAdministration, OralAnimalsAntineoplastic Combined Chemotherapy ProtocolsBiological AvailabilityCell Membrane PermeabilityColonic NeoplasmsFluorouracilHumansMaleMiceMice, Inbred BALB CNanoparticlesOrganoplatinum CompoundsOxaliplatinRatsEmulsionsFluorouracilOrganoplatinum CompoundsOxaliplatin5-fluorouracildeoxycholic acid derivativeion-pairing complexnanoemulsionoral deliveryoxaliplatin

Identifiers

PMID27942212
PMCPMC5138023
OpenAlexW2558830623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.